Patent · US Active

Methods and nucleic acids for analyses of cell proliferative disorders

US9670546B2 · kind B2 · utility

2Cited by

1References

5Claims

0Family size

Assignee

EPIGENOMICS AG · DE

Inventors

Dimo Dietrich · Berlin, DE
Ralf Lesche · Berlin, DE
Anne Fassbender · Berlin, DE
Manuel Krispin · Berlin, DE
Joern Dietrich · Berlin, DE

Key dates

Filing date	Jul 15, 2009
Grant date	Jun 6, 2017
Priority date	—
Expiry date	Jul 15, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/158
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention provides methods, nucleic acids and kits for determining the prognosis of a subject having cell proliferative disorder, preferably cancer. The invention discloses genomic sequences the methylation patterns of which have utility for the improved detection of said disorder, thereby enabling the improved diagnosis and treatment of patients.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.